NCT02991040View on ClinicalTrials.gov

Study to Evaluate Safety and Efficacy of Revanesse® Ultra + vs Revanesse® Ultra for Correction of NLF

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Nasolabial Fold Correction
Interventions
DEVICE

Revanesse Ultra+ (with lidocaine)

Bilateral nasolabial fold trial to compare the safety and efficacy profiles of Revanesse® Ultra + (with lidocaine) to Revanesse® Ultra (comparator)

DEVICE

Revanesse Ultra

Comparator without lidocaine

Trial Locations (1)

37215

Tennessee Clinical Research Center, Nashville

All Listed Sponsors
lead

Prollenium Medical Technologies Inc.

INDUSTRY

NCT02991040 - Study to Evaluate Safety and Efficacy of Revanesse® Ultra + vs Revanesse® Ultra for Correction of NLF | Biotech Hunter | Biotech Hunter